Revenue

The custom apparel leader partners with a top agency to expand its reach into sports, entertainment, and universities. Here's what the deal means for fans.

A new pharma-tech alliance aims to leverage quantum computing and AI to create safer opioids, but the non-binding deal faces significant hurdles.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Responding to social media demand, Whataburger brings back the Monterey Melt and Chicken Fajita Taco, while introducing a new value-focused wrap.

Newly public AI firm Fusemachines unveils an ambitious 2026 growth plan, but faces significant financial hurdles and deep investor skepticism.

Leveraging a fleet of vintage F-104 jets, Starfighters Space raises $40M and goes public, aiming to disrupt the small satellite launch market.

Facing declining revenue, Cardlytics brings back former CFO David Evans, who led its 2018 IPO, in a strategic bet on experience for its next chapter.

A new alliance led by engineering giant AtkinsRéalis will deliver the Midlands Rail Hub, a project promising vast economic growth and 300 extra trains daily.

Revelstoke Mountain Resort unveils new luxury homes, fueling its transformation into a year-round hub amid a local housing crunch and soaring demand.

Vancouver-based TRUBAR agrees to a C$201M buyout by Turkish food conglomerate ETİ Gıda, marking a major move in the booming plant-based snack market.

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

With trial data showing an average 23% body weight loss, Novo Nordisk's new combination drug CagriSema could usher in a powerful new era for medicine.

Pending home sales fell nearly 6% as high mortgage rates and economic jitters sideline both buyers and sellers, creating a deeply uneven national market.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

IIM Udaipur is the first IIM to offer a two-week campus immersion, giving MBA aspirants a unique trial run of B-school life before they commit.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Struggling Inno Holdings rolls the dice with a massive reverse stock split to avoid delisting, but grim financials and a brutal market reaction raise alarms.

After a challenging year marked by a mine fire and merger pains, Core Natural Resources is back online, signaling a major financial turnaround for 2026.

A new FDA approval for an EGFR-mutated lung cancer therapy cuts treatment from hours to minutes, offering new hope and convenience for thousands of patients.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?